Int Urol Nephrol 2020 Feb 01
High-sensitivity Troponin I Predicts Galectin-3 in Chronic Kidney Disease Patients.
Chan GC, Ho PJ, Li J, Lee EJC, Chua HR, Lau T, Sethi S, Teo BW
Plasma galectin-3 (pG3) regulates inflammation. B-type natriuretic peptide (BNP), high-sensitivity Troponin I (hsTnI), and pG3 concentrations are elev ...
Read More
Source: PubMed
Int Urol Nephrol 2020 Feb 01
Sodium and urea excretion as determinants of urine output in autosomal dominant polycystic kidney disease patients on V2 receptor antagonists: impact of dietary intervention.
Côté G, Asselin-Thompstone L, Mac-Way F, René de Cotret P, Lacroix C, Desmeules S, Agharazii M
Tolvaptan, a vasopressin V2 receptor antagonist, slows the decline in renal function in autosomal dominant polycystic kidney disease (ADPKD). However, ...
Read More
Source: PubMed
J Anal Toxicol 2020 Feb 02
CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine.
Basiliere S, Kerrigan S
Mitragyna speciosa (Kratom) has emerged as a recreational drug and a substance of medicinal intrigue. Although the drug was initially used recreationa ...
Read More
Source: PubMed
J. Alzheimers Dis. 2020 Jan 28
Elevated Urinary AD7c-NTP Levels in Older Adults with Hypertension and Cognitive Impairment.
Zhang Y, Li Y, Wang R, Sha G, Jin H, Ma L
Hypertension, a common chronic disease, is associated with cognitive impairment. Cognitive impairment, especially Alzheimer's disease (AD), seriously ...
Read More
Source: PubMed
Spectrochim Acta A Mol Biomol Spectrosc
Sensitive imprinted optical sensor based on mesoporous structure and green nanoparticles for the detection of methamphetamine in plasma and urine.
Mandani S, Rezaei B, Ensafi AA
Methamphetamine (MA), a psychoactive substance with many medicinal applications in different countries, has destructive impacts on the nervous system ...
Read More
Source: PubMed
Int Urol Nephrol 2020 Feb 01
High-sensitivity Troponin I Predicts Galectin-3 in Chronic Kidney Disease Patients.
Chan GC, Ho PJ, Li J, Lee EJC, Chua HR, Lau T, Sethi S, Teo BW
Plasma galectin-3 (pG3) regulates inflammation. B-type natriuretic peptide (BNP), high-sensitivity Troponin I (hsTnI), and pG3 concentrations are elev ...
Read More
Source: PubMed
Int Urol Nephrol 2020 Feb 01
Sodium and urea excretion as determinants of urine output in autosomal dominant polycystic kidney disease patients on V2 receptor antagonists: impact of dietary intervention.
Côté G, Asselin-Thompstone L, Mac-Way F, René de Cotret P, Lacroix C, Desmeules S, Agharazii M
Tolvaptan, a vasopressin V2 receptor antagonist, slows the decline in renal function in autosomal dominant polycystic kidney disease (ADPKD). However, ...
Read More
Source: PubMed
J Anal Toxicol 2020 Feb 02
CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine.
Basiliere S, Kerrigan S
Mitragyna speciosa (Kratom) has emerged as a recreational drug and a substance of medicinal intrigue. Although the drug was initially used recreationa ...
Read More
Source: PubMed
J. Alzheimers Dis. 2020 Jan 28
Elevated Urinary AD7c-NTP Levels in Older Adults with Hypertension and Cognitive Impairment.
Zhang Y, Li Y, Wang R, Sha G, Jin H, Ma L
Hypertension, a common chronic disease, is associated with cognitive impairment. Cognitive impairment, especially Alzheimer's disease (AD), seriously ...
Read More
Source: PubMed
Spectrochim Acta A Mol Biomol Spectrosc
Sensitive imprinted optical sensor based on mesoporous structure and green nanoparticles for the detection of methamphetamine in plasma and urine.
Mandani S, Rezaei B, Ensafi AA
Methamphetamine (MA), a psychoactive substance with many medicinal applications in different countries, has destructive impacts on the nervous system ...
Read More
Source: PubMed
Int Urol Nephrol 2020 Feb 01
High-sensitivity Troponin I Predicts Galectin-3 in Chronic Kidney Disease Patients.
Chan GC, Ho PJ, Li J, Lee EJC, Chua HR, Lau T, Sethi S, Teo BW
Plasma galectin-3 (pG3) regulates inflammation. B-type natriuretic peptide (BNP), high-sensitivity Troponin I (hsTnI), and pG3 concentrations are elev ...
Read More
Source: PubMed
Int Urol Nephrol 2020 Feb 01
Sodium and urea excretion as determinants of urine output in autosomal dominant polycystic kidney disease patients on V2 receptor antagonists: impact of dietary intervention.
Côté G, Asselin-Thompstone L, Mac-Way F, René de Cotret P, Lacroix C, Desmeules S, Agharazii M
Tolvaptan, a vasopressin V2 receptor antagonist, slows the decline in renal function in autosomal dominant polycystic kidney disease (ADPKD). However, ...
Read More
Source: PubMed
J Anal Toxicol 2020 Feb 02
CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine.
Basiliere S, Kerrigan S
Mitragyna speciosa (Kratom) has emerged as a recreational drug and a substance of medicinal intrigue. Although the drug was initially used recreationa ...
Read More
Source: PubMed
J. Alzheimers Dis. 2020 Jan 28
Elevated Urinary AD7c-NTP Levels in Older Adults with Hypertension and Cognitive Impairment.
Zhang Y, Li Y, Wang R, Sha G, Jin H, Ma L
Hypertension, a common chronic disease, is associated with cognitive impairment. Cognitive impairment, especially Alzheimer's disease (AD), seriously ...
Read More
Source: PubMed
Spectrochim Acta A Mol Biomol Spectrosc
Sensitive imprinted optical sensor based on mesoporous structure and green nanoparticles for the detection of methamphetamine in plasma and urine.
Mandani S, Rezaei B, Ensafi AA
Methamphetamine (MA), a psychoactive substance with many medicinal applications in different countries, has destructive impacts on the nervous system ...
Read More
Source: PubMed
Int Urol Nephrol 2020 Feb 01
High-sensitivity Troponin I Predicts Galectin-3 in Chronic Kidney Disease Patients.
Chan GC, Ho PJ, Li J, Lee EJC, Chua HR, Lau T, Sethi S, Teo BW
Plasma galectin-3 (pG3) regulates inflammation. B-type natriuretic peptide (BNP), high-sensitivity Troponin I (hsTnI), and pG3 concentrations are elev ...
Read More
Source: PubMed
Int Urol Nephrol 2020 Feb 01
Sodium and urea excretion as determinants of urine output in autosomal dominant polycystic kidney disease patients on V2 receptor antagonists: impact of dietary intervention.
Côté G, Asselin-Thompstone L, Mac-Way F, René de Cotret P, Lacroix C, Desmeules S, Agharazii M
Tolvaptan, a vasopressin V2 receptor antagonist, slows the decline in renal function in autosomal dominant polycystic kidney disease (ADPKD). However, ...
Read More
Source: PubMed
J Anal Toxicol 2020 Feb 02
CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine.
Basiliere S, Kerrigan S
Mitragyna speciosa (Kratom) has emerged as a recreational drug and a substance of medicinal intrigue. Although the drug was initially used recreationa ...
Read More
Source: PubMed
J. Alzheimers Dis. 2020 Jan 28
Elevated Urinary AD7c-NTP Levels in Older Adults with Hypertension and Cognitive Impairment.
Zhang Y, Li Y, Wang R, Sha G, Jin H, Ma L
Hypertension, a common chronic disease, is associated with cognitive impairment. Cognitive impairment, especially Alzheimer's disease (AD), seriously ...
Read More
Source: PubMed
Spectrochim Acta A Mol Biomol Spectrosc
Sensitive imprinted optical sensor based on mesoporous structure and green nanoparticles for the detection of methamphetamine in plasma and urine.
Mandani S, Rezaei B, Ensafi AA
Methamphetamine (MA), a psychoactive substance with many medicinal applications in different countries, has destructive impacts on the nervous system ...
Read More
Source: PubMed
Int Urol Nephrol 2020 Feb 01
High-sensitivity Troponin I Predicts Galectin-3 in Chronic Kidney Disease Patients.
Chan GC, Ho PJ, Li J, Lee EJC, Chua HR, Lau T, Sethi S, Teo BW
Plasma galectin-3 (pG3) regulates inflammation. B-type natriuretic peptide (BNP), high-sensitivity Troponin I (hsTnI), and pG3 concentrations are elev ...
Read More
Source: PubMed
Int Urol Nephrol 2020 Feb 01
Sodium and urea excretion as determinants of urine output in autosomal dominant polycystic kidney disease patients on V2 receptor antagonists: impact of dietary intervention.
Côté G, Asselin-Thompstone L, Mac-Way F, René de Cotret P, Lacroix C, Desmeules S, Agharazii M
Tolvaptan, a vasopressin V2 receptor antagonist, slows the decline in renal function in autosomal dominant polycystic kidney disease (ADPKD). However, ...
Read More
Source: PubMed
J Anal Toxicol 2020 Feb 02
CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine.
Basiliere S, Kerrigan S
Mitragyna speciosa (Kratom) has emerged as a recreational drug and a substance of medicinal intrigue. Although the drug was initially used recreationa ...
Read More
Source: PubMed
J. Alzheimers Dis. 2020 Jan 28
Elevated Urinary AD7c-NTP Levels in Older Adults with Hypertension and Cognitive Impairment.
Zhang Y, Li Y, Wang R, Sha G, Jin H, Ma L
Hypertension, a common chronic disease, is associated with cognitive impairment. Cognitive impairment, especially Alzheimer's disease (AD), seriously ...
Read More
Source: PubMed
Spectrochim Acta A Mol Biomol Spectrosc
Sensitive imprinted optical sensor based on mesoporous structure and green nanoparticles for the detection of methamphetamine in plasma and urine.
Mandani S, Rezaei B, Ensafi AA
Methamphetamine (MA), a psychoactive substance with many medicinal applications in different countries, has destructive impacts on the nervous system ...
Read More
Source: PubMed
Int Urol Nephrol 2020 Feb 01
High-sensitivity Troponin I Predicts Galectin-3 in Chronic Kidney Disease Patients.
Chan GC, Ho PJ, Li J, Lee EJC, Chua HR, Lau T, Sethi S, Teo BW
Plasma galectin-3 (pG3) regulates inflammation. B-type natriuretic peptide (BNP), high-sensitivity Troponin I (hsTnI), and pG3 concentrations are elev ...
Read More
Source: PubMed
Int Urol Nephrol 2020 Feb 01
Sodium and urea excretion as determinants of urine output in autosomal dominant polycystic kidney disease patients on V2 receptor antagonists: impact of dietary intervention.
Côté G, Asselin-Thompstone L, Mac-Way F, René de Cotret P, Lacroix C, Desmeules S, Agharazii M
Tolvaptan, a vasopressin V2 receptor antagonist, slows the decline in renal function in autosomal dominant polycystic kidney disease (ADPKD). However, ...
Read More
Source: PubMed
J Anal Toxicol 2020 Feb 02
CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine.
Basiliere S, Kerrigan S
Mitragyna speciosa (Kratom) has emerged as a recreational drug and a substance of medicinal intrigue. Although the drug was initially used recreationa ...
Read More
Source: PubMed
J. Alzheimers Dis. 2020 Jan 28
Elevated Urinary AD7c-NTP Levels in Older Adults with Hypertension and Cognitive Impairment.
Zhang Y, Li Y, Wang R, Sha G, Jin H, Ma L
Hypertension, a common chronic disease, is associated with cognitive impairment. Cognitive impairment, especially Alzheimer's disease (AD), seriously ...
Read More
Source: PubMed
Spectrochim Acta A Mol Biomol Spectrosc
Sensitive imprinted optical sensor based on mesoporous structure and green nanoparticles for the detection of methamphetamine in plasma and urine.
Mandani S, Rezaei B, Ensafi AA
Methamphetamine (MA), a psychoactive substance with many medicinal applications in different countries, has destructive impacts on the nervous system ...
Read More
Source: PubMed
Int Urol Nephrol 2020 Feb 01
High-sensitivity Troponin I Predicts Galectin-3 in Chronic Kidney Disease Patients.
Chan GC, Ho PJ, Li J, Lee EJC, Chua HR, Lau T, Sethi S, Teo BW
Plasma galectin-3 (pG3) regulates inflammation. B-type natriuretic peptide (BNP), high-sensitivity Troponin I (hsTnI), and pG3 concentrations are elev ...
Read More
Source: PubMed
Int Urol Nephrol 2020 Feb 01
Sodium and urea excretion as determinants of urine output in autosomal dominant polycystic kidney disease patients on V2 receptor antagonists: impact of dietary intervention.
Côté G, Asselin-Thompstone L, Mac-Way F, René de Cotret P, Lacroix C, Desmeules S, Agharazii M
Tolvaptan, a vasopressin V2 receptor antagonist, slows the decline in renal function in autosomal dominant polycystic kidney disease (ADPKD). However, ...
Read More
Source: PubMed
J Anal Toxicol 2020 Feb 02
CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine.
Basiliere S, Kerrigan S
Mitragyna speciosa (Kratom) has emerged as a recreational drug and a substance of medicinal intrigue. Although the drug was initially used recreationa ...
Read More
Source: PubMed
J. Alzheimers Dis. 2020 Jan 28
Elevated Urinary AD7c-NTP Levels in Older Adults with Hypertension and Cognitive Impairment.
Zhang Y, Li Y, Wang R, Sha G, Jin H, Ma L
Hypertension, a common chronic disease, is associated with cognitive impairment. Cognitive impairment, especially Alzheimer's disease (AD), seriously ...
Read More
Source: PubMed
Spectrochim Acta A Mol Biomol Spectrosc
Sensitive imprinted optical sensor based on mesoporous structure and green nanoparticles for the detection of methamphetamine in plasma and urine.
Mandani S, Rezaei B, Ensafi AA
Methamphetamine (MA), a psychoactive substance with many medicinal applications in different countries, has destructive impacts on the nervous system ...
Read More
Source: PubMed
